Tokyo, Japan

Takahiro Ochiya

USPTO Granted Patents = 44 


 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 48(Granted Patents)


Location History:

  • Chou-ku, Tokyo, JP (2010)
  • Tokyo-to, JP (2014)
  • Tokyo, JP (2000 - 2024)

Company Filing History:

goldMedal28 out of 222 
 
National Cancer Center
 patents
silverMedal17 out of 3,472 
 
Toray Industries, Inc.
 patents
bronzeMedal5 out of 140 
 
Dainippon Sumitomo Pharma Co., Ltd.
 patents
45 out of 54 
 
Koken Company, Limited
 patents
54 out of 4 
 
Theoria Science Inc.
 patents
63 out of 39 
 
3-d Matrix, Ltd.
 patents
72 out of 3 
 
Ds Pharma Biomedical Co., Ltd.
 patents
82 out of 200 
 
Daiichi Pharmaceutical Co., Ltd.
 patents
91 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents
101 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
111 out of 9 
 
Japan As Represented by President of National Cancer Center
 patents
121 out of 18 
 
Kewpie Corporation
 patents
131 out of 1 
 
Cynity Co., Ltd.
 patent
141 out of 1,007 
 
Shiseido Company, Limited
 patents
151 out of 6,892 
 
Sumitomo Chemical Company, Limited
 patents
161 out of 11 
 
Gene Techno Science Co., Ltd.
 patents
171 out of 81 
 
Asahi Kasei Pharma Corporation
 patents
181 out of 2 
 
Asahi Pharma Corporation
 patents
191 out of 223 
 
Sii Nanotechnology Inc.
 patents
203 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2025

Loading Chart...
Loading Chart...
Loading Chart...
44 patents (USPTO):Explore Patents

Title: Unveiling the Inventive Journey of Takahiro Ochiya

Introduction: Takahiro Ochiya, a prolific inventor based in Tokyo, Japan, has made significant contributions to the field of medical diagnostics with an impressive portfolio of 36 patents. His groundbreaking work in the detection of pancreatic and prostate cancers has revolutionized the way these diseases are diagnosed and monitored.

Latest Patents:

1. Method of examining the possibility of a subject having pancreatic cancer: Ochiya's innovation involves measuring GPRC5C present in an exosome in a specimen collected from the subject, providing a novel approach to identifying pancreatic cancer at an early stage.

2. Prostate cancer detection kit or device, and detection method: His invention includes a kit or device for detecting prostate cancer, comprising a nucleic acid capable of binding to a miRNA in a subject's sample, offering a precise method for prostate cancer detection.

Career Highlights: Ochiya has lent his expertise to renowned institutions such as the National Cancer Center and Toray Industries, Inc. His dedication to advancing medical technology has paved the way for improved diagnostic tools in the fight against cancer.

Collaborations: Throughout his career, Ochiya has collaborated with esteemed colleagues such as Satoko Kozono and Hiroko Sudo, collectively contributing to the development of innovative medical solutions.

Conclusion: Takahiro Ochiya's innovative spirit and commitment to progress have not only shaped the landscape of medical diagnostics but have also instilled hope in the fight against cancer. His pioneering work serves as a testament to the power of innovation in improving healthcare outcomes and saving lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…